Previous Page  4 / 10 Next Page
Information
Show Menu
Previous Page 4 / 10 Next Page
Page Background

Volume 8

Journal of Clinical & Experimental Pathology

ISSN : 2161-0681

Euro Pathology 2018 | Hematologic Oncology 2018

June 20-21, 2018

Page 25

Notes:

conference

series

.com

15

th

EUROPEAN PATHOLOGY CONGRESS

&

LEUKEMIA AND HEMATOLOGIC ONCOLOGY

June 20-21, 2018 | Paris, France

14

th

International Conference on

JOINT EVENT

Qing Kay Li, J Clin Exp Pathol 2018, Volume 8

DOI: 10.4172/2161-0681-C1-044

Accurate sub-classification of lung cancer using small biopsy samples based on updated WHO and

IASLC criteria

T

he new 2015 edition of the WHO classification and recommendations of IASLC (International Association of Study of

Lung Cancer) emphasize the importance of accurate sub-classification of lung cancers for targeted therapy. Lung cancer

is a heterogeneous group of neoplasms and accurate diagnosis and sub-classification on small biopsies can be challenging.

Recent systematic reviews and meta-analyses have shown that interobserver disagreement rates on the sub-classification of

non–small cell lung cancer (NSCLC) are approximately 10-20% in resected specimens and 20-30% in small biopsy specimen

without immunohistochemical (IHC) stains. The morphological heterogeneity of the lung cancer is also correlated with certain

molecular alterations. Therefore, it is necessary to introduce newly updated guidelines of WHO and IASLC into our daily

practice to improve the accuracy of sub-classification of lung cancer for targeted therapy, particularly in small biopsy specimens.

Biography

Qing Kay Li is an Associate Professor of Pathology and Oncology at the Johns Hopkins Medical Institutions. Her areas of clinical expertise include Surgical Pathology,

Cytopathology, and Oncological Pathology. She is also a Faculty and PI at Johns Hopkins Biomarker Discovery Center. She serves as Editorial Board Member for several

journals; Committee Member of the American Society of Cytopathology, Papanicolaou Society of Cytopathology, NIH/NCI cancer working groups; study sections of

government agents and private organizations. She has more than 100 publications, including several book chapters and books.

qli23@jhmi.edu

Qing Kay Li

Sidney Kimmel Comprehensive Cancer Center Johns Hopkins, USA

The Johns Hopkins Medical Institutions, USA